NMD4C Investigators Awarded $5.7 Million as Part of National Team to Advance 3D Models for Brain and Neuromuscular Research
NMD4C investigators are part of a national research team recently awarded $5.7 million in infrastructure funding from the Canada Foundation for Innovation (CFI) to support the development of advanced 3D human tissue models for brain and neuromuscular research.
This nationally funded initiative brings together researchers from The Ottawa Hospital, the University of Ottawa, and the University of Toronto, and is co‑led by Dr. Michael Rudnicki, an NMD4C investigator and an internationally recognized leader in neuromuscular research. The leadership team also includes Dr. Penney Gilbert (University of Toronto) and Dr. Mireille Khacho (University of Ottawa), both of whom are active contributors to neuromuscular research in Canada and engaged members of the NMD4C community. These investigators are contributors to the broader research team, reflecting the range of neuromuscular expertise represented within the NMD4C community.
The infrastructure supported through this grant will enable multiple laboratories to generate and study 3D neuromuscular and neural tissue models, including systems that combine nerve and muscle tissues. These shared platforms will accelerate discovery, foster collaboration across institutions, and provide hands‑on research opportunities for trainees nationwide.
Dr. Khacho is also serving as the lead for the 2026 NMD4C Basic Research Summer School, further strengthening the connection between cutting‑edge national research infrastructure and the training of the next generation of neuromuscular scientists and clinician‑researchers.
Read OHRI’s Full Announcement
NMD4C continues to support collaborative neuromuscular research and training through its national initiatives. Researchers and trainees interested in cross‑institutional opportunities may also wish to explore our NMD4C Collaborative Research Training Awards, with the current competition closing May 5, 2026.
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.